• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ⅲ期活动期舌鳞状细胞癌的间质近距离放射治疗及颈部淋巴结清扫术

Interstitial brachytherapy and neck dissection for Stage III squamous cell carcinoma of the mobile tongue.

作者信息

Ihara Nobumaro, Shibuya Hitoshi, Yoshimura Ryoichi, Oota Sayako, Miura Masahiko, Watanabe Hiroshi

机构信息

Department of Radiology, Graduate School, Tokyo Medical and Dental University, 5-45 Yushima 1-Chome, Bunkyo-ku, Tokyo 113-8519, Japan.

出版信息

Acta Oncol. 2005;44(7):709-16. doi: 10.1080/02841860500267881.

DOI:10.1080/02841860500267881
PMID:16227161
Abstract

The purpose of this study is to describe the cause-specific survival rate, local control rate, salvage rate of neck metastasis, and post-treatment eating and speaking conditions for stage III mobile tongue squamous cell carcinomas and its subgroups. Between 1968 and 1999, 117 previously untreated patients with stage III mobile tongue carcinomas underwent mainly brachytherapy with external beam irradiation (EBRT) and neck dissection. A multivariate analysis was performed for the cause-specific survival rate on the various factors. The 1-, 3- and 5-year cause-specific survival rates for all patients were 76%, 54% and 54%, respectively. The 1-, 3- and 5-year primary control rates for all patients were 67.6%, 63.4% and 59.2%, respectively. There were statistically significant differences in cause-specific survival rates among stage III subgroups of T3N0, T1-2N1 and T3N1 (p = 0.0002). Our treatment method for patients with stage III mobile tongue squamous cell carcinoma was effective and acceptable.

摘要

本研究旨在描述Ⅲ期可活动舌鳞状细胞癌及其亚组的病因特异性生存率、局部控制率、颈部转移挽救率以及治疗后的进食和说话情况。1968年至1999年间,117例未经治疗的Ⅲ期可活动舌癌患者主要接受了近距离放疗、外照射放疗(EBRT)和颈部清扫术。对各种因素的病因特异性生存率进行了多因素分析。所有患者的1年、3年和5年病因特异性生存率分别为76%、54%和54%。所有患者的1年、3年和5年原发灶控制率分别为67.6%、63.4%和59.2%。T3N0、T1-2N1和T3N1的Ⅲ期亚组之间病因特异性生存率存在统计学显著差异(p = 0.0002)。我们对Ⅲ期可活动舌鳞状细胞癌患者的治疗方法是有效且可接受的。

相似文献

1
Interstitial brachytherapy and neck dissection for Stage III squamous cell carcinoma of the mobile tongue.Ⅲ期活动期舌鳞状细胞癌的间质近距离放射治疗及颈部淋巴结清扫术
Acta Oncol. 2005;44(7):709-16. doi: 10.1080/02841860500267881.
2
Analysis of treatment results for oral tongue cancer.口腔舌癌治疗结果分析
Laryngoscope. 2002 Apr;112(4):616-25. doi: 10.1097/00005537-200204000-00005.
3
[Prognostic factors in epidermoid carcinoma of the mobile tongue classified as T1-T2].[舌活动部T1-T2期表皮样癌的预后因素]
Ann Otolaryngol Chir Cervicofac. 2001 Oct;118(5):315-22.
4
[Relevant factors and management for patients with squamous carcinoma in tongue without clinical cervical lymphatic node metastasis].[舌鳞状细胞癌无临床颈淋巴结转移患者的相关因素及管理]
Zhonghua Kou Qiang Yi Xue Za Zhi. 2003 Jan;38(1):5-8.
5
[Results of stage I and II tongue squamous cell carcinomas treated with different modalities].[不同治疗方式治疗的I期和II期舌鳞状细胞癌的结果]
Zhonghua Zhong Liu Za Zhi. 2008 Apr;30(4):302-5.
6
Is glossectomy necessary for late nodal metastases without clinical local recurrence after initial brachytherapy for N0 tongue cancer? A retrospective experience in 111 patients who received salvage therapy for cervical failure.对于N0期舌癌初次近距离放疗后出现晚期淋巴结转移但无临床局部复发的患者,是否有必要进行舌切除术?111例接受挽救性治疗以解决颈部治疗失败问题患者的回顾性经验。
Jpn J Clin Oncol. 2006 Jan;36(1):3-6. doi: 10.1093/jjco/hyi218. Epub 2006 Jan 17.
7
[Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].[125例cT1-2N0期舌鳞状细胞癌患者术后复发相关因素分析]
Ai Zheng. 2007 Jun;26(6):661-5.
8
Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.早期舌癌对侧N0颈部的治疗:选择性颈部清扫术与观察对比
Laryngoscope. 2006 Mar;116(3):461-5. doi: 10.1097/01.mlg.0000195366.91395.9b.
9
Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.间质高剂量率近距离放射疗法联合颈清扫术治疗头颈癌
Head Neck. 2005 Dec;27(12):1035-41. doi: 10.1002/hed.20278.
10
Treatment results and prognostic factors in oral tongue cancer: analysis of 80 patients.口腔舌癌的治疗结果及预后因素:80例患者分析
Int J Oral Maxillofac Surg. 2006 Jun;35(6):506-13. doi: 10.1016/j.ijom.2006.01.006. Epub 2006 Feb 28.

引用本文的文献

1
The Role of Brachytherapy in the Management of Oral Squamous Cell Carcinoma: A Systematic Review.近距离放射治疗在口腔鳞状细胞癌管理中的作用:一项系统评价
J Clin Med. 2025 Aug 26;14(17):6033. doi: 10.3390/jcm14176033.
2
198Au grain implantation for early tongue cancer in patients of advanced age or poor performance status.198Au 颗粒植入治疗高龄或体能状态差的早期舌癌患者。
J Radiat Res. 2013 Nov 1;54(6):1125-30. doi: 10.1093/jrr/rrt060. Epub 2013 May 17.
3
Current status and perspectives of brachytherapy for head and neck cancer.
头颈部癌近距离放射治疗的现状与展望
Int J Clin Oncol. 2009 Feb;14(1):2-6. doi: 10.1007/s10147-008-0859-y. Epub 2009 Feb 20.